Elucidating the role of fatty acid reprogramming in ovarian cancer: insights cross-talk between blood, subcutaneous fat, and ovarian cancer tissues
Frontiers in Oncology · 30.04.2025 · 15
DOI: 10.3389/fonc.2025.1530487 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 30.04.2025. Verfasst von Xiaocui Zhong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chongqing Postdoctoral Science Foundation, Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission.
Abstract (Originalsprache)
Introduction
Aberrant fatty acid (FA) metabolism is increasingly recognized as a significant factor in ovarian cancer (OC) progression, although the comprehensive metabolic alterations across different body tissues remain unclear.
Methods
In this study, sixteen OC patients and twenty-nine non-cancer (NC) patients were recruited for metabolic profiling using a global and targeted metabolomic strategy based on a gas chromatography-hydrogen flame ionization detector (GC-FID). The patient survival was followed up to 3 years, and PFS was calculated.
Results
Our findings revealed distinct metabolite profiles that differentiate OC from NC groups across all sample types. We found seven, nine, and thirteen significant metabolites in subcutaneous fat, plasma, and ovarian tissue respectively. In particular, docosahexaenoic acid (DHA) and arachidonic acid (AA) levels were notably elevated in all sample types of OC patients. Furthermore, receiver operating characteristic (ROC) analysis highlight that three plasma FA showed the best specificity and sensitivity in differentiating the OC group from the NC group (Area Under The Curve, AUC > 0.89), including caprylic acid, myristoleic acid, and tetracosaenoic acid. Most of the significant FA in subcutaneous fat and ovarian tissue showed a high risk of OC. However, caprylic acid and tetracosanoic acid were identified as protective factors in the plasma sample. We also found that high levels of linoelaidic acid in subcutaneous fat and palmitelaidic acid in ovarian tissue were associated with poor prognosis. Pathway analysis indicated upregulation of fatty acid synthesis, inflammatory signaling, and ferroptosis pathways in OC patients.
Discussion
This study reveals a coordinated reprogramming of FA metabolism across multiple biospecimens in OC patients. Our results suggest that specific fatty acids may contribute to OC progression through dysregulation of fatty acid synthesis, inflammatory signaling, and ferroptosis. These findings offer mechanistic insights into OC progression and highlighting potential biomarkers and targeted therapeutic interventions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Occupational and Environmental Hygiene, School of Public Health and Management, Research Center for Medicine and Social Development, Innovation Center for Social Risk Governance in Health, Chongqing Medica…
- Department of Obstetrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Liggins Institute, The University of Auckland, Auckland, New Zealand.
Förderung
- Chongqing Postdoctoral Science Foundation
- Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission
Zitieren
APA
Zhong, X., Bilal, M., Zhou, Y., Yang, X., Qin, Z., Li, Q., Yang, Y., Han, T. L., & Li, M. (2025). Elucidating the role of fatty acid reprogramming in ovarian cancer: insights cross-talk between blood, subcutaneous fat, and ovarian cancer tissues. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1530487
Vancouver
Zhong X, Bilal M, Zhou Y, Yang X, Qin Z, Li Q, et al. Elucidating the role of fatty acid reprogramming in ovarian cancer: insights cross-talk between blood, subcutaneous fat, and ovarian cancer tissues. Frontiers in Oncology. 2025;15. doi:10.3389/fonc.2025.1530487
BibTeX
@article{Zhong2025,
author = {Zhong, Xiaocui and Bilal, Mamona and Zhou, Yanqiu and Yang, Xiaojia and Qin, Zuchao and Li, Qibing and Yang, Yang and Han, Ting-Li and Li, Min},
title = {Elucidating the role of fatty acid reprogramming in ovarian cancer: insights cross-talk between blood, subcutaneous fat, and ovarian cancer tissues},
journal = {Frontiers in Oncology},
year = {2025},
volume = {15},
doi = {10.3389/fonc.2025.1530487}
}
EUVIMED